Patients with ankylosing spondylitis and low disease activity because of anti-TNF-alpha therapy have higher TRAIL levels than controls: a potential compensatory effect
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/1039
PMID: 24976690
DOI: 10.1155/2014/798060
ISSN: 0962-9351
Date issued
2014Journal title
MEDIATORS OF INFLAMMATION
Type of content
Artigo